Skip to main content
. 2018 Mar 21;38(2):BSR20171208. doi: 10.1042/BSR20171208

Table 3. The significantly enriched GO annotations (-log10 (P-value) > 5).

No. GO term −log10 (P-value) Protein
1 Nucleus 41.69 SLC2A4RG; PDX1; NIP7; UPF3A; ZNF655; RFC5; TBX2; ZNF576; CINP; JDP2; OSR2; ZNF282
2 Protein binding 31.67 PDZD4; ARFRP1; PDX1; NIP7; UPF3A; ZNF655; TIMM44; TBX2; CD81; MLPH
3 Zinc ion binding 17.24 SLC2A4RG; ZNF655; ZNF576; MLPH; OSR2; ZNF282
4 Cytoplasm 13.73 SLC2A4RG; UMODL1; PDZD4; IER2; UPF3A; RABEP2; MLPH
5 Cytoplasm 13.73 SLC2A4RG; UMODL1; PDZD4; IER2; UPF3A; RABEP2; MLPH
6 Integral to membrane 12.66 UMODL1
7 Metal ion binding 12.28 SLC2A4RG; ZNF655; ZNF576; MLPH; OSR2; ZNF282
8 Plasma membrane 10.74 UMODL1; GRM5
9 Membrane 10.74 TIMM44; CD81
10 Regulation of transcription, DNA-dependent 10.66 SLC2A4RG; ZNF655; ZNF576; JDP2; ZNF282
11 Extracellular region 10.00 UMODL1; NOG
12 Transcription 9.09 SLC2A4RG; ZNF655; ZNF576; JDP2; ZNF282
13 Transcription factor activity 9.04 SLC2A4RG; PDX1; TBX2; JDP2
14 Sequence-specific DNA binding 7.6 PDX1; TBX2; JDP2
15 Integral to plasma membrane 6.99 GRM5; CD81
16 Intracellular 6.67 SLC2A4RG; ARFRP1; ZNF655; ZNF576; CAPN6; OSR2; ZNF282
17 Nucleotide binding 6.6 ARFRP1; UPF3A; TIMM44;RFC5
18 DNA binding 6.19 ZNF655; ZNF576; ZNF282
19 Development 6.08 PDX1; TBX2
20 Positive regulation of cell proliferation 5.67 PDX1; TBX2; CD81; OSR2